Rhinitis causing the rhinitis. Rhinitis medicamentosa is a form of drug-induced nonallergic rhinitis which is associated with nasal congestion brought on by the use of certain oral medications (primarily sympathomimetic amine and 2-imidazoline derivatives) and topical decongestants (e.g., oxymetazoline, phenylephrine, xylometazoline, and naphazoline nasal sprays) that constrict the blood vessels in the lining of the nose. Chronic rhinitis is a form of atrophy of the mucous membrane and glands of the nose. Chronic form of dryness of the mucous membranes. Chronic rhinitis associated with polyps in the nasal cavity. Most prominent pathological changes observed are nasal airway epithelial metaplasia in which
Nasal administration transfer of drugs is achievable but the possibility of olfactory delivery of therapeutically relevant doses to humans remains to be demonstrated. Nasal administration Nasal administration is a route of administration in which drugs are insufflated through the nose. It can be a form of either topical administration or systemic administration, as the drugs thus locally delivered can go on to have either purely local or systemic effects. Nasal sprays are locally acting drugs such as decongestants for cold and allergy treatment, whose systemic effects are usually minimal. Examples of systemically active drugs available as nasal sprays are migraine drugs, nicotine